{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:19Z","timestamp":1787016919051,"version":"build-2736575974"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,1,17]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In the UK and Ireland, severe and complex obesity is managed in specialist weight management services (SWMS), which provide multicomponent lifestyle interventions to support weight loss, and use of medication if available. Liraglutide 3 mg (LIRA 3 mg) is an effective weight-loss medication, but weight loss in individual patients is variable, and its efficacy has not been assessed in SWMS. This study aims to investigate whether a targeted prescribing pathway for LIRA 3 mg with multiple prespecified stopping rules could help people with severe obesity and established complications achieve \u226515% weight loss in order to determine whether this could be considered a clinically effective and cost-effective strategy for managing severe and complex obesity in SWMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      In this 2-year, multicentre, open-label, real-world randomised controlled trial, 384 adults with severe and complex obesity (defined as body mass index \u226535 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      plus either prediabetes, type 2 diabetes, hypertension or sleep apnoea) will be randomised via a 2:1 ratio to receive either standard SWMS care (n=128) or standard SWMS care plus a targeted prescribing pathway for LIRA 3 mg with prespecified stopping rules at 16, 32 and 52 weeks (n=256).\n                    <\/jats:p>\n                    <jats:p>The primary outcome is to compare the proportion of participants achieving a weight loss of \u226515% at 52 weeks with a targeted prescribing pathway versus standard care. Secondary outcomes include a comparison of (1) the weight loss maintenance at 104 weeks and (2) the budget impact and cost effectiveness between the two groups in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Health Research Authority and the Medicines and Healthcare products Regulatory Authority in UK, the Health Products Regulatory Authority in Ireland, the North West Deanery Research Ethics Committee (UK) and the St Vincent\u2019s University Hospital European Research Ethics Committee (Ireland) have approved the study. The findings of the study will be published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov\u2014Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03036800\">NCT03036800<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                    <jats:p>European Clinical Trials Database\u2014Identifier: EudraCT Number 2017-002998-20.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-034137","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T04:25:27Z","timestamp":1581654327000},"page":"e034137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03036800","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03036800","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-1515","authenticated-orcid":false,"given":"Dimitris","family":"Papamargaritis","sequence":"first","affiliation":[{"name":"Diabetes Research Centre, Leicester General Hospital, University of Leicester College of Medicine Biological Sciences and Psychology, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werd","family":"Al-Najim","sequence":"additional","affiliation":[{"name":"Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lim","sequence":"additional","affiliation":[{"name":"Obesity and Endocrinology Clinical Research Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Crane","sequence":"additional","affiliation":[{"name":"Institute of Diabetes, Endocrinology and Obesity (IDEO), Guy's and St Thomas' NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Lean","sequence":"additional","affiliation":[{"name":"Human Nutrition, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"le Roux","sequence":"additional","affiliation":[{"name":"Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"McGowan","sequence":"additional","affiliation":[{"name":"Institute of Diabetes, Endocrinology and Obesity (IDEO), Guy's and St Thomas' NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"O'Shea","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, St Vincent\u2019s University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Webb","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, Leicester General Hospital, University of Leicester College of Medicine Biological Sciences and Psychology, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wilding","sequence":"additional","affiliation":[{"name":"Obesity and Endocrinology Clinical Research Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, Leicester General Hospital, University of Leicester College of Medicine Biological Sciences and Psychology, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2025120600221907000_10.2.e034137.1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12551"},{"key":"2025120600221907000_10.2.e034137.2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/obr.12601","article-title":"Commissioning guidance for weight assessment and management in adults and children with severe complex obesity","volume":"19","author":"Welbourn","year":"2018","journal-title":"Obes Rev"},{"key":"2025120600221907000_10.2.e034137.3","doi-asserted-by":"crossref","first-page":"204253331351247","DOI":"10.1177\/2042533313512479","article-title":"Eligibility for bariatric surgery among adults in England: analysis of a national cross-sectional survey","volume":"5","author":"Ahmad","year":"2014","journal-title":"JRSM Open"},{"key":"2025120600221907000_10.2.e034137.4","unstructured":"Gatineau M , Hancock C , Holman N . Public health England adult obesity and type 2 diabetes, 2014."},{"key":"2025120600221907000_10.2.e034137.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.14.1829"},{"key":"2025120600221907000_10.2.e034137.6","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr033"},{"key":"2025120600221907000_10.2.e034137.7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cob.12248","article-title":"Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK","volume":"8","author":"Wilding","year":"2018","journal-title":"Clin Obes"},{"key":"2025120600221907000_10.2.e034137.8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/oby.20662","article-title":"Eight-Year weight losses with an intensive lifestyle intervention: the look ahead study","volume":"22","year":"2014","journal-title":"Obesity"},{"key":"2025120600221907000_10.2.e034137.9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (direct): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"The Lancet"},{"key":"2025120600221907000_10.2.e034137.10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jhn.12611","article-title":"Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity","volume":"32","author":"McCombie","year":"2019","journal-title":"J Hum Nutr Diet"},{"key":"2025120600221907000_10.2.e034137.11","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12066"},{"key":"2025120600221907000_10.2.e034137.12","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.42","article-title":"Tier 3 specialist weight management service and pre-bariatric multicomponent weight management programmes for adults with obesity living in the UK: a systematic review","volume":"2","author":"Alkharaiji","year":"2019","journal-title":"Endocrinol Diab Metab"},{"key":"2025120600221907000_10.2.e034137.13","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.070052"},{"key":"2025120600221907000_10.2.e034137.14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00012"},{"key":"2025120600221907000_10.2.e034137.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1081"},{"key":"2025120600221907000_10.2.e034137.16","first-page":"37","article-title":"Long-Term weight loss maintenance for obesity: a multidisciplinary approach","volume":"9","author":"Montesi","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025120600221907000_10.2.e034137.17","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.120"},{"key":"2025120600221907000_10.2.e034137.18","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12578"},{"key":"2025120600221907000_10.2.e034137.19","unstructured":"National Institute for Health and Care Excellence . Obesity: identification, assessment and management. Available: https:\/\/www.nice.org.uk\/guidance\/cg189\/chapter\/1-recommendations [Accessed 12 Feb 2019]."},{"key":"2025120600221907000_10.2.e034137.20","first-page":"25","article-title":"The rewards and challenges of setting up a tier 3 adult weight management service in primary care","volume":"1","author":"Hughes","year":"2015","journal-title":"Br J Obes"},{"key":"2025120600221907000_10.2.e034137.21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.155"},{"key":"2025120600221907000_10.2.e034137.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411892"},{"key":"2025120600221907000_10.2.e034137.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.9676"},{"key":"2025120600221907000_10.2.e034137.24","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2016.52"},{"key":"2025120600221907000_10.2.e034137.25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"The Lancet"},{"key":"2025120600221907000_10.2.e034137.26","doi-asserted-by":"crossref","unstructured":"Wadden TA , Walsh OA , Berkowitz RI , et al . Intensive behavioral therapy for obesity combined with liraglutide 3.0 Mg: a randomized controlled trial. Obesity 2018.","DOI":"10.1002\/oby.22359"},{"key":"2025120600221907000_10.2.e034137.27","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/oby.21629","article-title":"Early weight loss with liraglutide 3.0 Mg predicts 1-year weight loss and is associated with improvements in clinical markers","volume":"24","author":"Fujioka","year":"2016","journal-title":"Obesity"},{"key":"2025120600221907000_10.2.e034137.28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-034137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:22:29Z","timestamp":1765009349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-034137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,13]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/bmjopen-2019-034137"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-034137","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}